Medicare Data Offers Positive News For Drug-Eluting Stent Makers
This article was originally published in The Gray Sheet
Executive Summary
Widespread adoption of drug-eluting stents has reduced repeat revascularization procedures without increasing the risk of death or heart attack, a retrospective study of 67,000 Medicare patients suggests